This definition appears very rarely
and is found in the following Acronym Finder categories:
- Organizations, NGOs, schools, universities, etc.
See other meanings of CHI
We have 204 other definitions for CHI
in our Acronym Attic
Samples in periodicals archive:
PT presentation and Q&A WHO: -- CEOs from three biotechnology companies: NuVasive (NASDAQ: NUVA), Omniox and Theravance (NASDAQ: THRX) -- Executives from BayBio, California Healthcare Institute and PwC US WHERE: Grand Hyatt San Francisco Conference Theatre 345 Stockton St.
The California Healthcare Institute board has elected a new leader for 2011, choosing Carl Hull, president and CEO of San Diego, Calif.
In creating a new redevelopment zone clustered around the University of Southern California's Health Sciences campus, Los Angeles leaders seek to tap into an industry that, according to the California Healthcare Institute, generated $32.
board of directors and the board of directors for California Healthcare Institute.
California Healthcare Institute member companies and partnering organizations that have taken on the challenges of creating new therapies for rare diseases and supporting the patients who suffer include: Amgen and BioMarin Pharmaceuticals, which has focused its mission solely to discovering and developing therapies for rare diseases, Genzyme, CureDuchenne, The Nicholas Conor Institute for Pediatric Cancer Research, and the Children's Rare Disease Network.
7 /PRNewswire-USNewswire/ -- The California Healthcare Institute (CHI) today launched the third episode of the podcast series, Cost Over Care: The Dangers of Bureaucratic Medicine.
24 /PRNewswire-USNewswire/ -- As state and federal policymakers search for ways to reduce healthcare costs, the California Healthcare Institute (CHI) launched the second episode of a podcast series, Cost Over Care: The Dangers of Bureaucratic Medicine, to inform policymakers and healthcare consumers about the dangers of a cost-based health care system.
About California Healthcare Institute CHI represents more than 250 leading biotechnology, medical device, diagnostics, and pharmaceutical companies, and public and private academic biomedical research organizations.